Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.38 |
| ▸ | F9 | P00740 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | RPA1 | P27694 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818549 | 0.96 | S1PR5 (0.37) | S1PR5S1PR4F9ALOX5CYP1A1 | |
| SCHEMBL25818482 | 0.95 | S1PR5 (0.39) | S1PR5S1PR4F9ALOX5PIM1 | |
| SCHEMBL25817796 | 0.92 | S1PR5 (0.42) | S1PR5S1PR4F9ALOX5CYP1A1 | |
| SCHEMBL25818453 | 0.91 | ALDH1A1 (0.36) | S1PR5S1PR4CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL24343408 | 0.91 | S1PR5 (0.43) | S1PR5S1PR4F9ALOX5PIM1 | |
| SCHEMBL25818529 | 0.90 | ALDH1A1 (0.34) | CYP1A1CYP1A2CYP1B1ALDH1A1MAPT | |
| SCHEMBL22161533 | 0.88 | HSD17B1 (0.37) | S1PR5S1PR4CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL25818432 | 0.88 | ALDH1A1 (0.37) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL25818441 | 0.88 | HSD17B1 (0.37) | S1PR5S1PR4CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL30855549 | 0.88 | SMN1; SMN2 (0.41) | S1PR5S1PR4CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917914-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917914-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | S1PR5 4785/4885S1PR4 4450/4885F9 1377/4885 |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | S1PR5 4785/4885S1PR4 4450/4885F9 1377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.